EMHTF - Emerald Health Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 542.08M
Enterprise Value 340.85M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.28
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.96
52-Week Change 3-88.04%
S&P500 52-Week Change 325.98%
52 Week High 33.4900
52 Week Low 30.2000
50-Day Moving Average 30.2483
200-Day Moving Average 30.9154

Share Statistics

Avg Vol (3 month) 3460.77k
Avg Vol (10 day) 3658.03k
Shares Outstanding 5160.99M
Float 128.35M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019

Profitability

Profit Margin -204.93%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-14.39%
Return on Equity (ttm)-19.36%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)2,795.90%
Gross Profit (ttm)-270.21k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.1290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)14.43
Current Ratio (mrq)1.14
Book Value Per Share (mrq)0.94

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A